Reply to L. Moreno et al Journal Article
| Authors: | Cheung, N. K. V.; Cheung, I. Y.; Ostrovnaya, I.; Kushner, B. H. |
| Article Title: | Reply to L. Moreno et al |
| Keywords: | cancer survival; overall survival; cancer risk; follow up; letter; phenotype; cancer immunotherapy; progression free survival; antineoplastic combined chemotherapy protocols; granulocyte macrophage colony stimulating factor; high risk patient; risk assessment; cancer genetics; cancer regression; antibodies, monoclonal; immunoglobulin g; neuroblastoma; isotretinoin; granulocyte-macrophage colony-stimulating factor |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 5 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-10 |
| Start Page: | 650 |
| End Page: | 651 |
| Language: | English |
| PUBMED: | 23520645 |
| PROVIDER: | scopus |
| DOI: | 10.1200/jco.2012.47.4593 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 May 2013" - "CODEN: JCOND" - ":doi 10.1200/JCO.2012.47.4593" - ": Chemicals/CASisotretinoin, 4759-48-2; Antibodies, Monoclonal; Granulocyte-Macrophage Colony-Stimulating Factor, 83869-56-1; Immunoglobulin G; Isotretinoin, 4759-48-2" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
196Ostrovnaya -
311Kushner -
648Cheung -
96Cheung